Skip to main content
OpenTrials

Clinical trial condition

Cytomegalovirus (CMV)-Positive Recipients

Explore clinical trials studying Cytomegalovirus (CMV)-Positive Recipients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Cytomegalovirus (CMV)-Positive Recipients trial results

Completed

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

NCT01877655

Conditions
Allogeneic, Hematopoietic Cell Transplant (HCT), Cytomegalovirus (CMV)-Positive Recipients
Locations
  • Site US10028 Birmingham, Alabama, United States
  • Site US10044 Tucson, Arizona, United States
  • Site US10035 San Francisco, California, United States
  • Site US10026 Stanford, California, United States
View all 83 locations
View Trial Details

Related conditions